Cardiac amyloidosis remains significantly underdiagnosed in patients undergoing TAVR: analysis of National Inpatient Sample.

Autor: Terentes-Printzios D; 1st Cardiology Department, Hippokration Hospital, National and Kapodistrian University of Athens, Athens, Greece., Antonopoulos AS; 1st Cardiology Department, Hippokration Hospital, National and Kapodistrian University of Athens, Athens, Greece., Omer M; Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA., Panagiotopoulos I; 1st Cardiology Department, Hippokration Hospital, National and Kapodistrian University of Athens, Athens, Greece., Toutouzas K; 1st Cardiology Department, Hippokration Hospital, National and Kapodistrian University of Athens, Athens, Greece., Tsioufis K; 1st Cardiology Department, Hippokration Hospital, National and Kapodistrian University of Athens, Athens, Greece., Elgendy I; Gill Heart Institute, University of Kentucky, Lexington, KY, USA., Vlachopoulos C; 1st Cardiology Department, Hippokration Hospital, National and Kapodistrian University of Athens, Athens, Greece.
Jazyk: angličtina
Zdroj: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis [Amyloid] 2023 Jun; Vol. 30 (2), pp. 246-247. Date of Electronic Publication: 2022 Dec 21.
DOI: 10.1080/13506129.2022.2159369
Databáze: MEDLINE
Nepřihlášeným uživatelům se plný text nezobrazuje